1. Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer
   Eleazar Omar Macedo-Pérez et al, 2014, Cancer Chemotherapy and Pharmacology CrossRef